Mariana Arruda

Mariana Arruda is an endocrinologist and the medical director at Novo Nordisk, a pharmaceutical company known for developing diabetes and obesity medications, including semaglutide. She has been actively involved in clinical research regarding the potential of semaglutide in treating Alzheimer's disease, particularly focusing on its effects in early stages of cognitive impairment.